Interleukin-1 beta induces interstitial collagenase gene expression and protein secretion in renal mesangial cells.
Degradation and tissue remodeling of the extracellular matrix in the normal glomerulus occur through the coordinate action of neutral metalloproteinases, which are in turn regulated by specific inhibitors. Many of these proteins can be secreted by mesangial cells. In the current study, gene regulation of a rat matrix metalloproteinase, interstitial collagenase and its tissue inhibitor of metalloproteinase-1 (TIMP-1), was investigated by Northern blot analysis. Stimulation of rat mesangial cell (RMC) collagenase by interleukin 1 beta (IL-1 beta) produced an increase (> 45-fold) in mRNA which peaked at 12 h. Lesser effects on the TIMP-1 mRNA expression were observed in response to IL-1 beta. Indomethacin did not influence the effect of IL-1 beta on collagenase, and exogenous prostaglandin E2 had no significant effect either on basal or IL-1 beta-stimulated mRNA levels. Collagenase was secreted into the media and showed minimal gelatinolytic activity at 36-h stimulation with IL-1 beta by zymography. By Western immunoblotting, we demonstrated with 24 h of stimulation the secretion of the active form of collagenase, which further increased after 36 h with IL-1 beta compared with the control. When RMC were retreated with genistein and herbimycin A, both inhibited collagenase mRNA induction by IL-1 beta. These data suggest that IL-1 beta stimulates interstitial collagenase synthesis and activation and that a tyrosine kinase pathway is involved in the signal transduction mechanisms and is not dependent on endogenous prostaglandin biosynthesis. Recently, a third interstitial collagenase (collagenase-3) has been identified from breast carcinoma. This cDNA is 84% identical to the rat interstitial collagenase cDNA probe we have utilized in this study and thus may represent the rat homologue of the human collagenase-3 now called matrix metalloproteinase (MMP)-13.
Daphna-Iken
D
D
Department of Medicine and Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Morrison
A R
AR
D000818:Animals; D002478:Cells, Cultured; D017364:Collagenases / Q000235:genetics* / Q000378:metabolism*; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004792:Enzyme Precursors / Q000378:metabolism; D005110:Extracellular Space / Q000201:enzymology*; D015870:Gene Expression / Q000187:drug effects*; D005920:Glomerular Mesangium / Q000166:cytology / Q000502:physiology*; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology*; D008297:Male; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins
D004791:Enzyme Inhibitors; D004792:Enzyme Precursors; D007375:Interleukin-1; D011994:Recombinant Proteins; D011505:Protein-Tyrosine Kinases; D011493:Protein Kinase C; D017364:Collagenases; C022440:procollagenase